## First-Dose Syncope Mechanism in Non-Selective Alpha Blockers ### Pathophysiology of Acute Orthostatic Hypotension **Key Point:** Non-selective α₁ blockers cause acute vasodilation by blocking both α₁A (urethral) and α₁B (vascular) receptors. The baroreceptor reflex is inadequate to compensate for the sudden drop in peripheral vascular resistance, resulting in profound hypotension and syncope. ### Step-by-Step Mechanism 1. **Acute α₁B blockade** → Vasodilation in arterioles and veins 2. **Reduced peripheral vascular resistance** → Sudden drop in blood pressure 3. **Baroreceptor activation** → Sympathetic reflex (tachycardia, vasoconstriction attempt) 4. **Inadequate compensation** → α₁ receptors already blocked → reflex cannot restore BP 5. **Result:** Syncope, diaphoresis, pallor (sympathetic activation without effective vasoconstriction) **High-Yield:** The **first-dose effect** is most pronounced 30 min–3 hours after initial dose, especially in patients who are volume-depleted, elderly, or on concurrent antihypertensives. ### Why Each Mechanism Is or Isn't Correct ```mermaid flowchart TD A["Doxazosin 1 mg (non-selective α₁ blocker)"]:::action --> B["Blocks α₁A + α₁B receptors"]:::outcome B --> C["Vascular α₁B blockade"]:::action C --> D["Vasodilation<br/>↓ Peripheral resistance"]:::outcome D --> E["Acute ↓ BP"]:::urgent E --> F{"Baroreceptor reflex?"}:::decision F -->|"Attempts vasoconstriction"| G["But α₁ receptors blocked!"]:::urgent G --> H["Reflex FAILS<br/>Syncope ensues"]:::urgent I["α₂ receptors INTACT<br/>Sympathetic tone ↑<br/>Tachycardia + diaphoresis"]:::outcome H --> I ``` ### Comparison: Why Other Mechanisms Are Wrong | Mechanism | Why Incorrect | Reality | |-----------|---------------|----------| | **α₂ blockade in brainstem** | Doxazosin does NOT block α₂ receptors; it is selective for α₁ | α₂ receptors remain functional; central sympathetic tone is preserved | | **Unopposed α₂ vasoconstriction** | α₂ receptors are inhibitory (presynaptic) and cause vasodilation, not constriction | This is backwards; α₁ blockade leaves α₂ effects unopposed, but α₂ alone cannot overcome the loss of α₁ vasoconstriction | | **Noradrenaline reuptake inhibition** | Doxazosin is an antagonist, not an uptake inhibitor; it does not increase catecholamine levels | This is a mechanism of tricyclic antidepressants or sympathomimetics, not α blockers | **Clinical Pearl:** The patient's **diaphoresis and tachycardia** indicate preserved sympathetic activation (α₂ and β-adrenergic effects intact), but the **profound hypotension** reveals that α₁-mediated vasoconstriction cannot be mounted because the receptors are blocked. ### Prevention and Management **Mnemonic:** **SLOW START** for non-selective α blockers - **S**tart low (0.5–1 mg) - **L**ie down after first dose - **O**bserve for 2–3 hours - **W**arn patient of first-dose effect - **S**low titration (increase every 1–2 weeks) - **T**ake at bedtime - **A**void concurrent vasodilators if possible - **R**ise slowly from supine - **T**reat with fluids and salt if volume-depleted **Warning:** Uroselective agents like tamsulosin do NOT cause first-dose syncope because they spare α₁B vascular receptors. [cite:KD Tripathi 8e Ch 6; Harrison 21e Ch 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.